Transcriptional co-activator with PDZ-binding motif (TAZ) defect caused structural changes in the pancreas, particularly islet cell shrinkage, and decreased insulin production and β-cell markers expression, leading to hyperglycemia.
[Cellular and Molecular Life Sciences]
Sorry, but the selected Zotpress account can't be found.
